Aesthetic injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Aesthetic Injectables under development
 - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
 - The report reviews the major players involved in the development of Aesthetic Injectables and list all their pipeline projects
 - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
 - The report provides key clinical trial data of ongoing trials specific to pipeline products
 - Recent developments in the segment/industry
 
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
 - Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
 - Identify and understand important and diverse types of Aesthetic Injectables under development
 - Develop market-entry and market expansion strategies
 - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
 - In-depth analysis of the product’s current stage of development, territory and estimated launch date
 
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc
 - Acro Biomedical Co Ltd
 - Advanced Aesthetic Technologies Inc
 - Aeon Astron Corporation
 - Aesthetic Medical Device
 - Allergan Aesthetics
 - Almirall Ltd
 - Beijing MeiYan KongJian Technology Co Ltd
 - BioPlus Co Ltd
 - Bioxis Pharmaceuticals
 - BMG Pharma SpA
 - Bmi Korea Co Ltd
 - CellPraxis
 - Celltrix AB
 - Collplant Biotechnologies Ltd
 - Dexlevo Inc
 - Dongkook Pharmaceutical Co Ltd
 - EternoGen Aesthetics LLC
 - Fillmed Laboratoires
 - G2GBIO Inc
 - Galderma SA
 - Genzyme Corp
 - Hallura Ltd
 - Histogen Inc
 - Hugel Inc
 - Innovia LLC
 - inSoma Bio Inc
 - Inventage Lab Inc
 - Jinwoo Bio Co Ltd
 - Juvenis Ltd
 - Khorionyx SA
 - Laboratoires Vivacy SAS
 - LG Chem Ltd
 - LifeSprout Inc
 - Medytox Inc
 - Merz North America Inc
 - Mesoestetic Pharma Group SL
 - Moma Therapeutics Inc
 - N8 Medical LLC
 - Oligo Medic Inc
 - PB&B SA
 - Peptron Inc
 - PetVivo Holdings Inc
 - Q-Med AB
 - RepliCel Life Sciences Inc
 - Samyang Biopharmaceuticals Corp
 - Sebana Medical Ltd
 - Shanghai Haohai Biological Technology Co Ltd
 - Shin Poong Pharm Co Ltd
 - Silk Medical Aesthetics Inc
 - Sinclair Pharma Ltd
 - Sofregen Medical Inc
 - SunMax Biotechnology Co Ltd
 - TEI Biosciences Inc
 - Tempo Therapeutics Inc
 - Teoxane SA
 - Tetratherix Pty Ltd
 - Tissueform Inc
 - University of California Santa Barbara
 - University of Missouri
 

